Biotech startups in France
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Biolevate | Paris | Series A | $34.4M | 2026-09-21 |
| WhiteLab Genomics | Paris | Series B | $26.0M | 2026-10-05 |
| Sweep | Montpellier | Series B | $73.0M | 2022-04-04 |
| Standing Ovation | Paris | Series B | $28.6M | 2026-03-31 |
| Generare | Paris | Series A | $23.1M | 2026-04-02 |
| En Carta Diagnostics | Paris | Seed | $3.4M | 2026-07-10 |
| BioFluff | Paris | Seed | $2.5M | 2026-09-02 |
| Amatera | Paris | Seed | $7.0M | 2026-03-04 |
8 rows of the CSV in 5 of its 18 columns.
- The 270 biotech startups in France have raised $2.7B in total.
- 34 of them closed their most recent round in the last 12 months, $419.0M combined.
- The largest of those rounds is Cyllene Therapeutics' $37.7M Series C, dated July 2026.
- The most recent is Rivercell's $25.0M seed round on 7 October 2026.
- Bpifrance is an investor in 20 of them, more than any other fund.
- Health care is the most common other sector, with 191 companies (71%).
- 30% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
28 of 270| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris | Series B | $26.0M | 2026-10-05 | $36.5M | Y Combinator, Omnes Capital | 11 to 50 | 2019 |
| Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris | Seed | $2.5M | 2026-09-02 | $3.2M | SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 | 1 to 10 | 2022 |
| En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. | Biotech | Paris | Seed | $3.4M | 2026-07-10 | $7.3M | CentraleSupélec Venture | 11 to 50 | 2022 |
| Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
| Standing Ovation | Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. | Biotech | Paris | Series B | $28.6M | 2026-03-31 | $53.8M | Bpifrance, Seventure Partners, Big Idea Ventures +2 | 11 to 50 | 2021 |
| Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| Bon Vivant | Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. | Biotech | Lyon | Series A | $29.4M | 2026-02-24 | $59.6M | Kima Ventures, Picus Capital, Sofinnova Partners +1 | 11 to 50 | 2021 |
| Lattice Medical | Lattice Medical makes 3D printed bioabsorbable medical devices for breast reconstruction. | Biotech | Loos | Series B | $50.0M | 2025-10-24 | $63.3M | Bpifrance, European Innovation Council, MedTech Innovator +1 | 11 to 50 | 2017 |
| Adcytherix | Adcytherix is a biopharmaceutical firm developing antibody drug conjugates. | Biotech | Marseille | Series A | $122.8M | 2025-10-16 | $155.1M | RA Capital Management, Pureos Bioventures, Pontifax +1 | 11 to 50 | 2023 |
| Genomines | Genomines is a biotechnology company that uses plants for mining. | Biotech | Paris | Series A | $45.0M | 2025-09-17 | $61.8M | Bpifrance, Elemental Impact, Lowercarbon Capital | 11 to 50 | 2021 |
| ENYO Pharma | ENYO Pharma is a biopharmaceutical company based in Lyon, France. | Biotech | Lyon | Series C | $7.0M | 2025-06-12 | $108.8M | Bpifrance, OrbiMed, Sofinnova Partners +2 | 11 to 50 | 2014 |
| NETRI | NETRI develops technologies for the pharmaceutical industry. | Biotech | Lyon | Series B | $5.1M | 2025-02-02 | $5.1M | Next Innov Prize | 11 to 50 | 2018 |
| Bioptimus | Bioptimus builds a foundation AI model for biology to accelerate scientific discovery. | Artificial intelligence | Paris | Series A | $41.0M | 2025-01-14 | Bpifrance, Headline, Cathay Innovation +1 | 1 to 10 | 2024 | |
| Starfish Bioscience | Starfish Bioscience develops microbiological solutions for agriculture and viticulture. | Biotech | Bordeaux | Seed | $757K | 2024-10-28 | Bpifrance, Seventure Partners, IRDI | 1 to 10 | 2023 | |
| Surge | Surge personalizes surgical patient care by predicting postoperative infections accurately. | Artificial intelligence | Illkirch-graffenstaden | Seed | $5.7M | 2024-03-27 | Bpifrance, Kima Ventures, Eurazeo +2 | 1 to 10 | 2021 | |
| HawkCell | HawkCell offers MRI solutions for veterinary clinics and preclinical research labs. | Biotech | Lyon | Series A | $5.5M | 2024-03-11 | $5.5M | Bpifrance, MIG Capital | 11 to 50 | 2018 |
| Kinvent | Kinvent develops assessment and training technologies and measuring and medical devices for rehabilitation and sports biomechanics. | Biotech | Montpellier | Series B | $17.4M | 2024-01-18 | Bpifrance, Eurazeo, Uni.Fund +2 | 51 to 100 | 2018 | |
| Antabio | Antabio is a biopharmaceutical company developing treatments that break antibacterial resistance. | Biotech | Labège | Series B | $27.0M | 2023-12-12 | Bpifrance, European Innovation Council, Omnes Capital +2 | 11 to 50 | 2009 | |
| CarThera | CarThera designs therapeutic ultrasound medical devices for treating brain disorders. | Biotech | Paris | Series B | $4.8M | 2023-12-11 | European Innovation Council, Supernova Invest, Unorthodox Ventures +1 | 1 to 10 | 2010 | |
| Abcely | Abcely is a biotech company developing a novel anti-cancer medication. | Biotech | Nantes | Seed | $2.6M | 2023-09-21 | GO CAPITAL, Angels Santé | 1 to 10 | 2022 | |
| AbolerIS Pharma | AbolerIS Pharma develops immuno-modulators for transplant rejection, graft-versus-host disease, and autoimmune diseases. | Biotech | Nantes | Series A | $29.2M | 2023-09-18 | Criteria Venture Tech, Sound Bioventures, Turenne Groupe | 11 to 50 | 2019 | |
| Gradient Denervation Technologies | Gradient Denervation Technologies develops a transvascular medical device for treating pulmonary hypertension. | Biotech | Paris | Series A | $15.0M | 2023-09-07 | MedTech Innovator, Sofinnova Partners, Thuja Capital +1 | 11 to 50 | 2019 | |
| aiherd | aiHerd provides AI-based livestock monitoring services for farmers. | Artificial intelligence | Nantes | Seed | $2.2M | 2023-02-24 | $4.5M | Bpifrance, VetAngels | 11 to 50 | 2020 |
| Echoliv | Echoliv develops medical-grade AI for liver ultrasound to assist radiologists and hepatologists. | Artificial intelligence | Paris | Pre-seed | $61K | 2022-07-07 | Bpifrance, WILCO, IMT Starter | 1 to 10 | 2021 | |
| Sweep | Sweep is a software company that helps businesses reduce their carbon emissions. | Biotech | Montpellier | Series B | $73.0M | 2022-04-04 | Coatue, Balderton Capital, New Wave (VC) +1 | 101 to 250 | 2020 | |
| ExactCure | ExactCure creates digital twins of patients to model how drugs act in the body. | Biotech | Nice | Seed | $1.1M | 2019-11-14 | OneRagtime | 1 to 10 | 2018 | |
| NGI | NGI is a creative advertising agency offering website development and graphic design services. | Biotech | Nantes | Series A | $11.8M | 2007-12-19 | Auriga Partners, Quest for Growth, Sanofi Ventures +1 | 11 to 50 | 2001 |
Table 1. Biotech startups in France: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 270.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| 2 | Bon Vivant | Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. | Biotech | Lyon | Series A | $29.4M | 2026-02-24 | $59.6M | Kima Ventures, Picus Capital, Sofinnova Partners +1 | 11 to 50 | 2021 |
| 3 | Standing Ovation | Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. | Biotech | Paris | Series B | $28.6M | 2026-03-31 | $53.8M | Bpifrance, Seventure Partners, Big Idea Ventures +2 | 11 to 50 | 2021 |
| 4 | WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris | Series B | $26.0M | 2026-10-05 | $36.5M | Y Combinator, Omnes Capital | 11 to 50 | 2019 |
| 5 | Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
| 6 | Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| 7 | En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. | Biotech | Paris | Seed | $3.4M | 2026-07-10 | $7.3M | CentraleSupélec Venture | 11 to 50 | 2022 |
| 8 | BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris | Seed | $2.5M | 2026-09-02 | $3.2M | SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 | 1 to 10 | 2022 |
Table 2. Biotech startups in France: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bpifrance | Government investment office | Maisons-alfort, France | 20 | 7% | 2 | Biolevate, Standing Ovation |
| 2 | Sofinnova Partners | Venture capital firm | Paris, France | 5 | 2% | 1 | Bon Vivant |
| 3 | Omnes Capital | Private equity firm | Paris, France | 4 | 1% | 1 | WhiteLab Genomics |
| 4 | Kima Ventures | Micro VC fund | Paris, France | 4 | 1% | 1 | Bon Vivant |
| 5 | Kurma Partners | Venture capital firm | Paris, France | 4 | 1% | ||
| 6 | European Innovation Council | Startup accelerator | Brussels, Belgium | 4 | 1% | ||
| 7 | Seventure Partners | Venture capital firm | Paris, France | 3 | 1% | 1 | Standing Ovation |
| 8 | Eurazeo | Private equity firm | Paris, France | 3 | 1% | ||
| 9 | Elaia | Venture capital firm | Paris, France | 3 | 1% | ||
| 10 | GO CAPITAL | Private equity firm | Rennes, France | 3 | 1% | ||
| 11 | Astanor Ventures | Venture capital firm | Luxembourg, Belgium | 2 | 1% | 2 | BioFluff, Standing Ovation |
| 12 | Andera Partners | Private equity firm | Paris, France | 2 | 1% | ||
| 13 | Joyance Partners | Venture capital firm | San Francisco, United States | 2 | 1% | 2 | BioFluff, Amatera |
| 14 | AgFunder | Micro VC fund | San Francisco, United States | 2 | 1% | 1 | Amatera |
| 15 | Supernova Invest | Venture capital firm | Paris, France | 2 | 1% |
Table 3. Biotech startups in France: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 191 | 71% | $2.3B |
| Software | 34 | 13% | $176.2M |
| Artificial intelligence | 18 | 7% | $169.7M |
| Hardware | 11 | 4% | $9.2M |
| Energy | 3 | 1% | |
| Education | 3 | 1% | $12.4M |
| Fintech | 1 | 0% | $4.4M |
Table 4. Biotech startups in France by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in France by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Paris | 93 | 34% |
| Lyon | 19 | 7% |
| Évry | 10 | 4% |
| Strasbourg | 8 | 3% |
| Marseille | 7 | 3% |
| Pessac | 7 | 3% |
| Nantes | 6 | 2% |
| Romainville | 6 | 2% |
| Toulouse | 4 | 1% |
| Bordeaux | 4 | 1% |
| Montpellier | 3 | 1% |
| Suresnes | 3 | 1% |
Table 6. Biotech startups in France by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 6% | $51.0M |
| September 2026 | 4 | 12% | $39.0M |
| July 2026 | 3 | 9% | $53.7M |
| June 2026 | 2 | 6% | $34.0M |
| May 2026 | 2 | 6% | $23.7M |
| April 2026 | 1 | 3% | $23.1M |
| March 2026 | 4 | 12% | $44.1M |
| February 2026 | 1 | 3% | $29.4M |
| January 2026 | 8 | 24% | $85.1M |
| December 2025 | 4 | 12% | $27.9M |
| November 2025 | 3 | 9% | $7.9M |
Table 7. Biotech startups in France: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 27 | 10% | $383.2M |
| 2025 | 46 | 17% | $552.2M |
| 2024 | 25 | 9% | $240.1M |
| 2023 | 25 | 9% | $446.7M |
| 2022 | 27 | 10% | $343.1M |
| 2021 | 24 | 9% | $303.8M |
Table 8. Biotech startups in France by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 24 | 9% |
| 2020 to 2022 | 57 | 21% |
| 2015 to 2019 | 87 | 33% |
| 2010 to 2014 | 50 | 19% |
| Before 2010 | 49 | 18% |
Table 9. Biotech startups in France by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 131 | 50% |
| 11 to 50 | 119 | 45% |
| 51 to 100 | 10 | 4% |
| 101 to 250 | 4 | 2% |
Table 10. Biotech startups in France by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in France. On 16 November 2026 that is 270 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 28 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 270 rows: 30 have no round amount, 0 no city and 97 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in France are on the list?
- 270, in the file dated 16 November 2026. 34 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 270 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.